Skip to main content
Caplight Logo









Guangzhou Huateng Biomedical Technology Co., Ltd.

Guangzhou Huateng Biomedical Technology Co., Ltd.

Private
GuangzhouHealthcare & Life Scienceshttps://htscience.com/

Last Round

Series B

Extension

Jan 1, 2026

Company Overview

Guangzhou Huateng Biomedical Technology Co., Ltd. is a biotechnology company that provides preclinical contract research organization (CRO) services, including animal model development, drug efficacy testing, and safety evaluation for pharmaceutical and medical device companies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Advanced Materials, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

polyethylene glycol derivativesPEG derivativesPEGylation reagentscontract research organizationCROdrug deliverypreclinical researchmonodisperse PEGmulti-arm PEGdrug conjugationpharmacokineticsPBPK modelingbiomarker discoverylab animal modelsbiotech servicescustom synthesis

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Guangzhou Huateng Biomedical Technology Co., Ltd. Comparables

Compare Guangzhou Huateng Biomedical Technology Co., Ltd. with similar companies based on industry and business-model similarity.

Guangzhou Huateng Biomedical Technology Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Xiamen Sinopeg Biotech Co., Ltd.
89%
BroadPharm
87%
Biopharma PEG Scientific Inc.
86%

Guangzhou Huateng Biomedical Technology Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series B ExtensionJan 1, 2026
Series BSep 21, 2024
Series A ExtensionAug 30, 2023
Series ASep 1, 2022
AngelMay 1, 2021

Guangzhou Huateng Biomedical Technology Co., Ltd. Investors

Notable investors and investment history

Guangzhou Huateng Biomedical Technology Co., Ltd. investors
InvestorRounds
China Environmental Protection FoundationAngel
Guangzhou Financial Holdings Fund ManagementSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 1, 2026

    Completed a Series B Extension funding round.

  • Sep 21, 2024

    Raised Series B round with Guangzhou Financial Holdings Fund Management.

Guangzhou Huateng Biomedical Technology Co., Ltd. Filings

Explore SEC and related filing metadata, where available.

Guangzhou Huateng Biomedical Technology Co., Ltd. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Guangzhou Huateng Biomedical Technology Co., Ltd.'s valuation, stock price, and market status.

Is Guangzhou Huateng Biomedical Technology Co., Ltd. a public or private company?

Guangzhou Huateng Biomedical Technology Co., Ltd. is a private company.

What is the current stock price of Guangzhou Huateng Biomedical Technology Co., Ltd.?

Guangzhou Huateng Biomedical Technology Co., Ltd. is a private company with no public stock price. Caplight tracks Guangzhou Huateng Biomedical Technology Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is Guangzhou Huateng Biomedical Technology Co., Ltd. worth (valuation)?

Valuation information for Guangzhou Huateng Biomedical Technology Co., Ltd. is not publicly available.

Can I buy Guangzhou Huateng Biomedical Technology Co., Ltd. stock?

Guangzhou Huateng Biomedical Technology Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Guangzhou Huateng Biomedical Technology Co., Ltd.'s last funding round?

Guangzhou Huateng Biomedical Technology Co., Ltd.'s most recent funding round was Series B Extension on January 1, 2026.

Who are the main investors in Guangzhou Huateng Biomedical Technology Co., Ltd.?

Key investors in Guangzhou Huateng Biomedical Technology Co., Ltd. include China Environmental Protection Foundation, Guangzhou Financial Holdings Fund Management.

Will Guangzhou Huateng Biomedical Technology Co., Ltd. IPO soon?

No public IPO plans have been announced for Guangzhou Huateng Biomedical Technology Co., Ltd..

How can I track Guangzhou Huateng Biomedical Technology Co., Ltd. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Guangzhou Huateng Biomedical Technology Co., Ltd.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersGuangzhou
Employee Range1
Year Founded2019
Last FundingJan 1, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?